Infanrix-IPV

Infanrix-IPV Uses, Dosage, Side Effects, Food Interaction and all others data.

Each single dose of 0.5 ml ampoule contains:

Diphtheria toxoid: ≥30 IUTetanus toxoid: ≥40 IUBordetella pertussis antigens toxid: 25 mcgFilamentous haemagglutinin: 25 mcgInactivated type 1 poliomyelitis virus D antigen: 40 unitsInactivated type 2 poliomyelitis virus D antigen: 8 unitsInactivated type 3 poliomyelitis virus D antigen: 32 unitsHaemophilus influenzae type b polysaccharide (conjugated to tetanus protein): 10 mcgProduction of specific antibodies to tetanus, diphtheria, and pertusis (active immunity). Conveys active immunity via stimulation of production of endogenously produced antibodies.

Diphtheriatoxoid:≥30IUTetanustoxoid:≥40IUBordetellapertussisantigenstoxid:25mcgFilamentoushaemagglutinin:25mcgInactivatedtype1poliomyelitisvirusDantigen:40unitsInactivatedtype2poliomyelitisvirusDantigen:8unitsInactivatedtype3poliomyelitisvirusDantigen:32unitsHaemophilusinfluenzaetypebpolysaccharide(conjugatedtotetanusprotein):10mcgProductionofspecificantibodiestotetanus,diphtheria,andpertusis(activeimmunity).Conveysactiveimmunityviastimulationofproductionofendogenouslyproducedantibodies.

Table Of contents

• Infanrix-IPV
• Uses
• Dosage
• Side Effect
• Precautions
• Interactions
• Uses during Pregnancy
• Uses during Breastfeeding
• Accute Overdose
• Food Interaction
• Half Life
• Volume of Distribution
• Clearance
• Interaction With other Medicine
• Contradiction
• Storage

Trade Name	Infanrix-IPV
Generic	DPT + Poliomyelitis + Haemophilus Influenzae Type B (HIB) Conjugate Vaccines
Type
Therapeutic Class	Vaccines, Anti-sera & Immunoglobulin
Manufacturer
Available Country	Canada, United States
Last Updated:	September 19, 2023 at 7:00 am

Uses

Haemophilus influenzae type B, diphtheria, tetanus, pertussis and poliomyelitis.

Dosage

Infanrix-IPV dosage

Primary Vaccination: 3 doses given at an interval of 1-2 months with booster 1 year after the primary vaccination around 16-18 months of age.

Precaution

Fever, acute illness, progressive chronic disease.

Interaction

There are no known drug interactions and none well documented.

Pregnancy & Breastfeeding use

Pregnancy Category- C

Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks

Contraindication

Pain, erythema, induration, fever, irritability.

Innovators Monograph

You find simplified version here Infanrix-IPV